(Q36521844)

14 August 2017

1 reference

title

Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future (English)

1 reference

14 August 2017

Anil Potti

1

1 reference

14 August 2017

Apar Kishor Ganti

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

709-716

1 reference

14 August 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

A new international staging system for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Adjuvant cancer chemotherapy after resection of carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)--the 4th study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Targeting signal transduction pathways in colorectal cancer--more than skin deep

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

Phenotypic heterogeneity in multiple myeloma families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.7.709

21 January 2018

Identifiers

DOI

10.1517/14712598.6.7.709

1 reference

14 August 2017

1 reference